EM2305F "NAFLD and Cardiovascular Risk: Translational Implications for Clinical Practice" (IM GR-051223)

Purpose and Overview

The global burden of non-alcoholic fatty liver disease (NAFLD) as a major cause of chronic liver disease continues to rise. Cardiovascular disease is a leading cause of morbidity and mortality in this patient population. This presentation summarizes recent advances in the understanding of cardiovascular disease in NAFLD and strategies for screening and management

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Discuss the physiologic changes in the cardiovascular system and cardiovascular outcomes in patients with NAFLD
  • Evaluate approaches to targeting cardiovascular risk in NAFLD clinical trials
  • Incorporate cardiovascular risk reduction strategies into your clinical practice for patients with NAFLD
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
Course expires: 

Photo: First Last, M.D.Lisa VanWagner, M.D.
Associate Professor of Internal Medicine
Director of Clinical Research
Division of Digestive and Liver Diseases

Available Credit

  • 1.00 AMA


Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome